* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Patient Notice of Financial Responsibility for Non
Survey
Document related concepts
Transcript
Patient Notice of Financial Responsibility for Non-Covered Testing NeoGenomics Laboratories is a medical laboratory that specializes in cancer genetics testing. Your physician has recommended a test be ordered that will provide clinical value to your personalized patient management plan. Unfortunately, certain tests are not covered and will be the responsibility of the patient. Here are the steps that take place when a test is ordered from NeoGenomics: 1. A physician orders a test from NeoGenomics that he / she believes will provide clinical value to the personalized patient management plan. 2. NeoGenomics will perform the testing and deliver the results back to the ordering physician. 3. NeoGenomics will bill the medical coverage provider of the patient and wait for a reply in the form of payment or denial. At the same time, the medical coverage provider will send an Explanation of Benefits to the patient that will explain the coverage decision. This is not a bill from NeoGenomics. 4. The medical coverage provider may deny coverage, leaving the patient with the financial responsibility. The medical coverage provider may pay a portion of the billed charges, leaving the patient to pay only the appropriate co-payment, co-insurance, or deductible for testing services. NeoGenomics will send a bill to the patient with details on payment options. NeoGenomics makes patient billing as flexible as possible when coverage is denied. We offer several payment options, including check, money order, credit / debit card, and payment plans Estimated patient responsibility amounts can be found on the second page. Please call our Billing Team to find out more at 866-776-5907. Rev. 011516 NeoTYPE Cancer Profiles Price Patient Estimated Responsibility NeoTYPE™ Myeloid Disorders Profile $2,600 $2,600 NeoTYPE™ Precision Profile for Solid Tumors $2,600 $2,600 $60 $60 Panels Price Patient Estimated Responsibility BTK Inhibitor Acquired Resistance Panel $780 $780 BTK Inhibitor Primary Susceptibility Panel $1,560 $1,560 Molecular Pathology Interpretation for NeoTYPE Cancer Profiles Other & Individual Tests Price Patient Estimated Responsibility AKT1 $390 ALK Other & Individual Tests Price Patient Estimated Responsibility $390 IKZF1 $390 $390 $390 $390 JAK3 $390 $390 APC $390 $390 KDM6A $390 $390 ASXL1 $600 $600 KDR $390 $390 ATM $390 $390 KRAS Exon 4 $675 $675 ATRX $390 $390 MET $450 $450 BCOR $390 $390 MLL $390 $390 BCORL1 $390 $390 MYD88 $390 $390 BTK $390 $390 NeoARRAY SNP/Cytogenetic Profile $1,950 $1,950 CALR $390 $390 NOTCH1 $1,200 $1,200 CARD11 $390 $390 PHF6 $390 $390 CBL $600 $600 PLC-Gamma-2 $390 $390 CBLB $390 $390 PTPN11 $425 $425 CBLC $390 $390 RAD21 $390 $390 CD79B $450 $450 RB1 $390 $390 CDH1 $390 $390 RET $390 $390 CDKN2A $390 $390 SETBP1 $175 $175 CSF1R $390 $390 SF3B1 $461 $461 CSF3R $644 $644 SMAD4 $390 $390 CTNNB1 $390 $390 SMARCB1 $390 $390 CUX1 $390 $390 SMC1A $390 $390 CXCR4 $390 $390 SMC3 $390 $390 DNMT3A $450 $450 SMO $390 $390 ERBB2 $390 $390 SRC $390 $390 ERBB4 $390 $390 SRSF2 $517 $517 ETV6 $616 $616 STAG2 $390 $390 EZH2 $750 $750 STAT3 $644 $644 FBXW7 $390 $390 STK11 $390 $390 FGFR1 $390 $390 TET2 $900 $900 FGFR2 $390 $390 TP53 $1,479 $1,479 FGFR3 $390 $390 U2AF1 $562 $562 GATA1 $390 $390 UGT1A1 $100 $100 GATA2 $390 $390 VHL $390 $390 GNA11 $390 $390 WT1 $600 $600 ZRSR2 $600 $600 GNAQ $390 $390 GNAS $1134 $1134 HNF1A $390 $390 HOXB13 $220 $220 HRAS $500 $500 Note: Patient responsibility amounts may vary depending on a variety of factors including the patient’s condition, diagnosis codes provided, medications, frequency of testing and results of previously ordered tests. Patient responsibility amounts are an estimate and may vary on a claim by claim basis. Rev. 011516